DIA 2013 49th Annual Meeting
Click here to go to the previous page
Advancing Endpoint Adjudication
Track
:
Track 07: Processes and Technologies for Clinical Research
Program Code:
335
Date:
Wednesday, June 26, 2013
Time:
10:15 AM to 11:45 AM
EST
Location:
252AB
CHAIR
:
Jonathan Seltzer, MD,MA,MBA,FACC (SCHNON), President and CEO, Applied Clinical Intelligence, LLC, United States
SPEAKER
(S):
Douglas Burgener, (SPKNON), Product Manager, EDC and Virtual Clinical Adjudication System (VCAS), Perceptive Informatics, United States Debra Montgomery, MSN,RN (SPKNON), eCRF Librarian, CDS III, Duke Clinical Research Institute, United States Nicole Pushlar, (SPKNON), Clinical Scientist, Clinical Trial Management, Boehringer Ingelheim Pharmaceuticals, Inc., United States
Description
CRO, sponsor, and agency perspectives on the evolution of clinical endpoint adjudication committees (EACs) will elucidate relevant definitions and emerging requirements substantiated by case studies and metrics from dozens of global programs/projects.
This session is a part of:
This session is a part of: